FTUS
ALNY icon

Flow Traders U.S.’s Alnylam Pharmaceuticals ALNY Stock Holding History

Flow Traders U.S.’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Buy
+715
New +$216K 0.01% 884
2026
Q1 		– Sell
-1,135
Closed -$451K – 989
2025
Q4 		$451K Buy
+1,135
New +$502K 0.01% 601
2025
Q3 		– Sell
-740
Closed -$241K – 923
2025
Q2 		$241K Buy
+740
New +$205K 0.01% 798
2025
Q1 		– Sell
-1,392
Closed -$328K – 906
2024
Q4 		$328K Buy
+1,392
New +$366K 0.01% 720

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Flow Traders U.S.'s ALNY Position: Q2 2026 in Review

Flow Traders U.S. opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 715 shares worth $215K. The stake represents 0.01% of the portfolio and ranks #884 among its holdings. This is a return to the name: Flow Traders U.S. previously reported a position in ALNY as recently as Q4 2025.

Flow Traders U.S. first reported a position in ALNY in Q4 2024 and has held it in 4 quarters since. The position peaked at $451K in Q4 2025. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Flow Traders U.S. held 715 shares of Alnylam Pharmaceuticals worth $215K as of Q2 2026.
  • Alnylam Pharmaceuticals was a new Flow Traders U.S. position in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.01% of Flow Traders U.S.'s portfolio in Q2 2026, its #884 holding.
  • Flow Traders U.S. first reported a position in Alnylam Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Flow Traders U.S.'s Alnylam Pharmaceuticals position peaked at $451K in Q4 2025.
  • 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.